PHARMACEUTICAL FORMULATION HAVING IMPROVED LIGHT STABILITY WHICH COMPRISES PITAVASTATINS AND COLORING AGENT WITH A MAXIMUM ABSORPTION VALUE AT A WAVELENGTH BETWEEN MORE THAN 500 NM AND NOT MORE THAN 600 NM

摘要

PURPOSE: A pharmaceutical formulation containing pitavastatins, coloring agent, and additional shielding agent is ensure light stability and to be used as a therapeutic agent for treating hyperlipidemia. CONSTITUTION: A pharmaceutical formulation contains pitavastatins, coloring agent with maximum absorption wave length at 500 nm to 600 nm, and additional shielding agent. The pitavastains include pitavastatin, pharmaceutically acceptable salt thereof, ester, hydrate, solvate, or combination thereof. The coloring agent is edible synthetic coloring agent or natural coloring agent. The additional shielding agent includes talc, titanium oxide, zinc oxide, kaolite, ferric chloride, ferric oxide, or mixture thereof.